Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: Involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling

Hormone and Metabolic Research

Volumn 46, Issue 8, 2014, Pages 568-573

  Ivey, R ^a   Desai, M ^a   Green, K ^a   Sinha Hikim, I ^a,b   Friedman, T C ^a,b   Sinha Hikim, A P ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; caspase 2; hepatic steatosis; high fat diet; iNOS; nicotine; oxidative stress

Indexed keywords

CASPASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INDUCTION; FATTY LIVER; INTRACELLULAR SIGNALING; LIPID DIET; LIVER CELL; MALE; MICROSCOPY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 2; DIET, HIGH-FAT; FATTY LIVER; HEPATOCYTES; MALE; MICE, INBRED C57BL; MICE, OBESE; MODELS, BIOLOGICAL; NICOTINE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION;

EID: 84904571184     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1375610     Document Type: Article

References (29)

1. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., Wang J., Chen C. S., Chen J., Wildman R. P., Klag M. J., Whelton P. K. Major causes of death among men and women in China. N Engl J Med: 2005; 353 1124 1134 (Pubitemid 41317435)
2. Barnes P. J. New concepts in chronic obstructive pulmonary disease. Ann Rev Med: 2003; 54 113 129 (Pubitemid 37386387)
3. Zaher C., Halbert R., Dubios R., George D., Nonikov D. Smoking-related diseases: the importance of COPD. Int J Tuberc Lung: 2004; 8 1423 1428 (Pubitemid 40070247)
4. Hudson N. L., Mannino D. M. Tobacco use: a chronic illness? J Community Health: 2010; 35 549 553
5. Hamabe A., Uto H., Imamura Y., Kusano K., Mawatari S., Kumagai K., Kure T., Tamai T., Moriuchi A., Sakiyama T., Oketani M., Ido A., Tsubouchi H. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol: 2011; 46 769 778
6. Zein C. O., Unalp A., Colvin R., Liu Y-C, McCullough A. J. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol: 2011; 54 753 759
7. Azzalini L., Ferrer E., Ramalho L. N., Moreno M., Dominguez M., Colmenero J., Peinado V. I., Barbera J. A., Arroyo V., Gines P., Caballeria J., Bataller R. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology: 2010; 5 1567 1576
8. Yuan H., Shyy J. Y., Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol: 2009; 51 535 547
9. Haslam D. W., James W. P. Obesity. Lancet: 2005; 366 1197 1209 (Pubitemid 41393598)
10. Chiolero A., Faeh D., Paccaud F., Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr: 2008; 87 801 809 (Pubitemid 351549222)
11. Postic C., Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest: 2008; 118 829 838 (Pubitemid 351364588)
12. Trauner M., Arrease M., Wangner M. Fatty liver and lipotoxicity. Biochem Biophys Acta: 2010; 1801 299 310
13. Kojima H., Sakurai S., Uemura M., Fukui H., Morimoto H., Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res: 2007; 31 01 S61 S66
14. Mantena S., King A., Andringa K., Eccleston H., Bailey S. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol: 2008; 44 1259 1272
15. Puri P., Mirshahl F., Cheung O., Natarajan R., Maher J. W., Kellum J. M., Sanyal A. J. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology: 2008; 134 568 576 (Pubitemid 351173040)
16. Ferreira D. M., Castro R. E., Machado M. V., Evangelista T., Silvestre A., Costa A., Coutinho J., Carepa F., Cortez-Pinto H., Rodrigues C. M. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia: 2011; 54 1788 1798
17. Friedman T. C., Sinha-Hikim I., Parveen M., Najjar S. M., Liu Y., Mangubat M., Shin C-S, Lyzlov A., Ivey R., Shaheen M., French S. W., Sinha-Hikim A. P. Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice. Endocrinology: 2012; 153 5809 5820
18. Lassus P., Opitz-Araya X., Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science: 2002; 297 1352 1354 (Pubitemid 34913174)
19. Braga M., Sinha Hikim A. P., Datta S., Ferrini M., Brown D., Kovacheva E. L., Gonzalez-Cadavid N. F., Sinha-Hikim I. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis: 2008; 13 822 832
20. Prasad V., Chandele A., Jagtap J. C., Kumar S., Shastry P. ROS-triggered caspase 2 activation and feedback amplification loop in b-carotene-induced apoptosis. Free Radic Biol Med: 2006; 41 431 442 (Pubitemid 44056011)
21. Tamm C., Zhivotovsky B., Ceccatelli S. Caspase-2 activation in neural stem cells undergoing stress-induced apoptosis. Apoptosis: 2008; 13 354 363
22. 2-terminal kinase and nitric oxide-mediated mitochondria-dependent intrinsic pathway signaling in cardiotoxin-induced muscle cell death: role of testosterone. Apoptosis: 2007; 12 1965 1978 (Pubitemid 47498228)
23. Biswas N., Mahato S. K., Chowdhury A. A., Manna A., Vinayagam J., Chatterjee S., Jaisankar P., Chaudhuri U., Bandyopadhyay S. CB3E induces iNOS expression by ROS-dependent JNK and ERK activation for apoptosis of leukemia cells. Apoptosis: 2012; 17 612 626
24. Fujita K., Nozaki Y., Yoneda M., Wada K., Takahashi H., Kirikoshi H., Inamori M., Saito S., Iwasaki T., Terauchi Y., Maeyama S., Nakajima A. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. Alcohol Clin Expt Res: 2010; 34 01 S18 S24
25. Sinha-Hikim I., Sinha-Hikim A. P., Shen R., Kim H., French S. W., Vaziri N. D., Crum A., Rajavashisth T. B., Norris K. C. A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Exp Mol Pathol: 2011; 91 419 428
26. Sinha-Hikim I., Friedman T. C., Shin C-S, Lee D., Ivey R., Sinha-Hikim A. P. Nicotine in combination with a high-fat diet causes intramyocellular mitochondrial abnormalities in male mice. Endocrinology: 2014; 155 865 872
27. Singh R., Wang Y., Schattenberg J. M., Xian Y., Czaja M. J. Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol: 2009; 297 G907 G917
28. Kathirvel E., Morgan K., Nandgiri G., Sandoval B. C., Caudill M. A., Bottiglieri T., French S. W., Morgan T. R. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol: 2010; 299 G1068 G1077
29. He S., Rehman H., Wright G. L., Zhong Z. Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic liver grafts. Transplantation: 2010; 89 291 298